Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;38(9):2032-2036.
doi: 10.1038/s41375-024-02337-0. Epub 2024 Jul 18.

Clinical and molecular characteristics of extramedullary acute myeloid leukemias

Tariq Kewan  1   2 , Waled S Bahaj  1 , Carmelo Gurnari  1   3 , Olisaemeka D Ogbue  1 , Sudipto Mukherjee  1 , Anjali Advani  1 , James R Cook  4 , Heesun J Rogers  4 , Hetty E Carraway  1 , Suresh K Balasubramanian  5 , Valeria Visconte  1 , Jaroslaw P Maciejewski  6
Affiliations

Clinical and molecular characteristics of extramedullary acute myeloid leukemias

Tariq Kewan et al. Leukemia. 2024 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Clinical, molecular and treatment characteristics for patients with extramedullary acute myeloid leukemia.
A Pie charts presenting the frequencies of extramedullary acute myeloid leukemia (eAML) subtypes and the most common locations for extramedullary involvement. CNS: central nervous system, GI: gastrointestinal. B Bar histogram presenting the most common molecular mutations in the eAML cohort compared to non-eAML patients Asterisks mark mutations with significant higher frequencies in the eAML cohort. C Bar histogram presenting the differences of specific mutations frequencies among patients with isolated and synchronous eAML. D Forest plot presenting the odd ratios (OR) for eAML based on univariable logistic regression analysis. E Kaplan Meier survival curve for eAML cases based on different treatment used. Allo-HCT: allogenic hematopoietic stem cell transplantation. F Forest plot presenting the hazard ratios for overall survival from univariable regression analysis.
See this image and copyright information in PMC

References

    1. Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017;17:263–7. 10.1016/j.clml.2017.02.027 - DOI - PubMed
    1. Kaur V, Swami A, Alapat D, Abdallah AO, Motwani P, Hutchins LF, et al. Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years. Hematology. 2018;23:17–24. 10.1080/10245332.2017.1333275 - DOI - PubMed
    1. Solh M, Solomon S, Morris L, Holland K, Bashey A. Extramedullary acute myelogenous leukemia. Blood Rev. 2016;30:333–9. 10.1016/j.blre.2016.04.001 - DOI - PubMed
    1. Ball S, Knepper TC, Deutsch YE, Samra W, Watts JM, Bradley TJ, et al. Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer. 2022;128:3880–7. 10.1002/cncr.34459 - DOI - PubMed
    1. Tallman MS. Extramedullary acute myeloid leukemia infiltrates. Leuk Res. 2004;28:1005–6. 10.1016/j.leukres.2004.03.021 - DOI - PubMed

LinkOut - more resources